Report Detail

Pharma & Healthcare Global Dexmethylphenidate Market Insights, Forecast to 2025

  • RnM3518069
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Dexmethylphenidate Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Dexmethylphenidate Market Size Growth Rate by Product
      • 1.4.2 Tablet
      • 1.4.3 Capsule
    • 1.5 Market by End User
      • 1.5.1 Global Dexmethylphenidate Market Size Growth Rate by End User
      • 1.5.2 Children(6-17 years)
      • 1.5.3 Adult
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Dexmethylphenidate Market Size
      • 2.1.1 Global Dexmethylphenidate Revenue 2014-2025
      • 2.1.2 Global Dexmethylphenidate Sales 2014-2025
    • 2.2 Dexmethylphenidate Growth Rate by Regions
      • 2.2.1 Global Dexmethylphenidate Sales by Regions
      • 2.2.2 Global Dexmethylphenidate Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Dexmethylphenidate Sales by Manufacturers
      • 3.1.1 Dexmethylphenidate Sales by Manufacturers
      • 3.1.2 Dexmethylphenidate Sales Market Share by Manufacturers
      • 3.1.3 Global Dexmethylphenidate Market Concentration Ratio (CR5 and HHI)
    • 3.2 Dexmethylphenidate Revenue by Manufacturers
      • 3.2.1 Dexmethylphenidate Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dexmethylphenidate Revenue Share by Manufacturers (2014-2019)
    • 3.3 Dexmethylphenidate Price by Manufacturers
    • 3.4 Dexmethylphenidate Manufacturing Base Distribution, Product Types
      • 3.4.1 Dexmethylphenidate Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Dexmethylphenidate Product Type
      • 3.4.3 Date of International Manufacturers Enter into Dexmethylphenidate Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Dexmethylphenidate Sales by Product
    • 4.2 Global Dexmethylphenidate Revenue by Product
    • 4.3 Dexmethylphenidate Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Dexmethylphenidate Breakdown Data by End User

    6 North America

    • 6.1 North America Dexmethylphenidate by Countries
      • 6.1.1 North America Dexmethylphenidate Sales by Countries
      • 6.1.2 North America Dexmethylphenidate Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Dexmethylphenidate by Product
    • 6.3 North America Dexmethylphenidate by End User

    7 Europe

    • 7.1 Europe Dexmethylphenidate by Countries
      • 7.1.1 Europe Dexmethylphenidate Sales by Countries
      • 7.1.2 Europe Dexmethylphenidate Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Dexmethylphenidate by Product
    • 7.3 Europe Dexmethylphenidate by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Dexmethylphenidate by Countries
      • 8.1.1 Asia Pacific Dexmethylphenidate Sales by Countries
      • 8.1.2 Asia Pacific Dexmethylphenidate Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Dexmethylphenidate by Product
    • 8.3 Asia Pacific Dexmethylphenidate by End User

    9 Central & South America

    • 9.1 Central & South America Dexmethylphenidate by Countries
      • 9.1.1 Central & South America Dexmethylphenidate Sales by Countries
      • 9.1.2 Central & South America Dexmethylphenidate Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Dexmethylphenidate by Product
    • 9.3 Central & South America Dexmethylphenidate by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Dexmethylphenidate by Countries
      • 10.1.1 Middle East and Africa Dexmethylphenidate Sales by Countries
      • 10.1.2 Middle East and Africa Dexmethylphenidate Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Dexmethylphenidate by Product
    • 10.3 Middle East and Africa Dexmethylphenidate by End User

    11 Company Profiles

    • 11.1 Novartis
      • 11.1.1 Novartis Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis Dexmethylphenidate Products Offered
      • 11.1.5 Novartis Recent Development
    • 11.2 Teva
      • 11.2.1 Teva Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teva Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teva Dexmethylphenidate Products Offered
      • 11.2.5 Teva Recent Development
    • 11.3 Intellipharmaceutics
      • 11.3.1 Intellipharmaceutics Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Intellipharmaceutics Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Intellipharmaceutics Dexmethylphenidate Products Offered
      • 11.3.5 Intellipharmaceutics Recent Development
    • 11.4 Impax Laboratories
      • 11.4.1 Impax Laboratories Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Impax Laboratories Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Impax Laboratories Dexmethylphenidate Products Offered
      • 11.4.5 Impax Laboratories Recent Development
    • 11.5 Sun Pharmaceutical
      • 11.5.1 Sun Pharmaceutical Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sun Pharmaceutical Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sun Pharmaceutical Dexmethylphenidate Products Offered
      • 11.5.5 Sun Pharmaceutical Recent Development
    • 11.6 Mylan
      • 11.6.1 Mylan Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Mylan Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Mylan Dexmethylphenidate Products Offered
      • 11.6.5 Mylan Recent Development
    • 11.7 Par Pharmaceutical
      • 11.7.1 Par Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Par Pharmaceutical Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Par Pharmaceutical Dexmethylphenidate Products Offered
      • 11.7.5 Par Pharmaceutical Recent Development
    • 11.8 Novel Laboratories
      • 11.8.1 Novel Laboratories Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Novel Laboratories Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Novel Laboratories Dexmethylphenidate Products Offered
      • 11.8.5 Novel Laboratories Recent Development
    • 11.9 Tris Pharma
      • 11.9.1 Tris Pharma Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Tris Pharma Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Tris Pharma Dexmethylphenidate Products Offered
      • 11.9.5 Tris Pharma Recent Development
    • 11.10 Rhodes Pharmaceuticals
      • 11.10.1 Rhodes Pharmaceuticals Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Rhodes Pharmaceuticals Dexmethylphenidate Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Rhodes Pharmaceuticals Dexmethylphenidate Products Offered
      • 11.10.5 Rhodes Pharmaceuticals Recent Development
    • 11.11 Lannett Company
    • 11.12 Adare Pharmaceuticals

    12 Future Forecast

    • 12.1 Dexmethylphenidate Market Forecast by Regions
      • 12.1.1 Global Dexmethylphenidate Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Dexmethylphenidate Revenue Forecast by Regions 2019-2025
    • 12.2 Dexmethylphenidate Market Forecast by Product
      • 12.2.1 Global Dexmethylphenidate Sales Forecast by Product 2019-2025
      • 12.2.2 Global Dexmethylphenidate Revenue Forecast by Product 2019-2025
    • 12.3 Dexmethylphenidate Market Forecast by End User
    • 12.4 North America Dexmethylphenidate Forecast
    • 12.5 Europe Dexmethylphenidate Forecast
    • 12.6 Asia Pacific Dexmethylphenidate Forecast
    • 12.7 Central & South America Dexmethylphenidate Forecast
    • 12.8 Middle East and Africa Dexmethylphenidate Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Dexmethylphenidate Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Dexmethylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
      The global Dexmethylphenidate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dexmethylphenidate market based on company, product type, end user and key regions.

      This report studies the global market size of Dexmethylphenidate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dexmethylphenidate in these regions.
      This research report categorizes the global Dexmethylphenidate market by top players/brands, region, type and end user. This report also studies the global Dexmethylphenidate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novartis
      Teva
      Intellipharmaceutics
      Impax Laboratories
      Sun Pharmaceutical
      Mylan
      Par Pharmaceutical
      Novel Laboratories
      Tris Pharma
      Rhodes Pharmaceuticals
      Lannett Company
      Adare Pharmaceuticals

      Market size by Product
      Tablet
      Capsule
      Market size by End User
      Children(6-17 years)
      Adult

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Dexmethylphenidate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Dexmethylphenidate market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Dexmethylphenidate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Dexmethylphenidate submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Dexmethylphenidate are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dexmethylphenidate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Dexmethylphenidate . Industry analysis & Market Report on Dexmethylphenidate is a syndicated market report, published as Global Dexmethylphenidate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dexmethylphenidate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,990.79
      4,486.18
      5,981.57
      3,515.64
      5,273.46
      7,031.29
      429,070.20
      643,605.30
      858,140.40
      277,433.52
      416,150.28
      554,867.04
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report